CD19 and B-cell chronic lymphocytic leukemia: A critical breakthrough in the use of CAR T cell therapy arrived when Dr. Carl June’s team at the University of Pennsylvania reported that three adult patients with advanced chronic lymphocytic leukemia (CLL) achieved complete or partial remission after receiving CD19-specific CAR T cell therapy (53, 54).